Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Metastatic Non-Clear Cell Renal Cancer
NCT01034878Phase 2Completed
- Sponsor
- Humanitas Research Hospital
- Start
- Dec 2009
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in non-clear cell renal cell carcinoma (nccRCC), sponsored by Humanitas Research Hospital. Started Dec 2009; status: completed.
02
Drugs
sunitinib
03
Conditions
non-clear cell renal cell carcinoma (nccRCC)
Beyond the preview
Go deeper on NCT01034878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01034878.